Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer's disease and progressive supranuclear palsy

• Published in: PloS one 2022-04, Vol.17 (4), p.e0266405-e0266405
• Main Authors: Iohan, Lukas da Cruz Carvalho, Lambert, Jean-Charles, Costa, Marcos R
• Format: Article
• Language: English
• Subjects: Age; Aged; Alzheimer Disease - metabolism; Alzheimer's disease; Analysis; Animal models; Animals; Bioinformatics; Biological activity; Biology and Life Sciences; Brain; Brain - metabolism; Computer and Information Sciences; Diagnosis; Gene expression; Genetic aspects; Humans; Inflammation; Information processing; Knowledge; Life Sciences; Medicine and Health Sciences; Metadata; Modelling; Myelination; Neurodegenerative diseases; Paralysis; Pathogenesis; Pathology; Progressive supranuclear palsy; Research and Analysis Methods; Risk analysis; Risk factors; Supranuclear Palsy, Progressive - metabolism; Synaptic transmission; Tau protein; tau Proteins - genetics; tau Proteins - metabolism; Tauopathies - metabolism
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0266405

A comprehensive understanding of the pathological mechanisms involved at different stages of neurodegenerative diseases is key for the advance of preventive and disease-modifying treatments. Gene expression alterations in the diseased brain is a potential source of information about biological processes affected by pathology. In this work, we performed a systematic comparison of gene expression alterations in the brains of human patients diagnosed with Alzheimer's disease (AD) or Progressive Supranuclear Palsy (PSP) and animal models of amyloidopathy and tauopathy. Using a systems biology approach to uncover biological processes associated with gene expression alterations, we could pinpoint processes more strongly associated with tauopathy/PSP and amyloidopathy/AD. We show that gene expression alterations related to immune-inflammatory responses preponderate in younger, whereas those associated to synaptic transmission are mainly observed in older AD patients. In PSP, however, changes associated with immune-inflammatory responses and synaptic transmission overlap. These two different patterns observed in AD and PSP brains are fairly recapitulated in animal models of amyloidopathy and tauopathy, respectively. Moreover, in AD, but not PSP or animal models, gene expression alterations related to RNA splicing are highly prevalent, whereas those associated with myelination are enriched both in AD and PSP, but not in animal models. Finally, we identify 12 AD and 4 PSP genetic risk factors in cell-type specific co-expression modules, thus contributing to unveil the possible role of these genes to pathogenesis. Altogether, this work contributes to unravel the potential biological processes affected by amyloid versus tau pathology and how they could contribute to the pathogenesis of AD and PSP.